IRIS
SCAVONE, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.423
NA - Nord America 2.833
AS - Asia 2.371
SA - Sud America 471
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 31
OC - Oceania 2
Totale 11.327
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.813
US - Stati Uniti d'America 2.756
SG - Singapore 839
IE - Irlanda 526
CN - Cina 456
BR - Brasile 395
IT - Italia 383
VN - Vietnam 369
HK - Hong Kong 327
GB - Regno Unito 185
DE - Germania 181
KR - Corea 99
UA - Ucraina 85
IN - India 68
JP - Giappone 64
GR - Grecia 48
CA - Canada 46
FI - Finlandia 34
BD - Bangladesh 32
TR - Turchia 30
FR - Francia 29
AR - Argentina 27
SE - Svezia 19
EC - Ecuador 18
ID - Indonesia 16
MX - Messico 16
NL - Olanda 15
PL - Polonia 14
ES - Italia 13
AT - Austria 12
CZ - Repubblica Ceca 12
BE - Belgio 11
IQ - Iraq 11
ZA - Sudafrica 11
CO - Colombia 10
VE - Venezuela 10
UZ - Uzbekistan 9
AL - Albania 7
PK - Pakistan 7
SA - Arabia Saudita 7
SC - Seychelles 7
CH - Svizzera 6
CL - Cile 5
IR - Iran 5
JM - Giamaica 5
HU - Ungheria 4
KG - Kirghizistan 4
LT - Lituania 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
BG - Bulgaria 3
DK - Danimarca 3
EG - Egitto 3
MA - Marocco 3
PR - Porto Rico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 11.133
Salva come PNG Salva come JPEG
Città #
Moscow 1.370
Dublin 523
San Jose 431
Singapore 408
Santa Clara 338
Hong Kong 322
Ashburn 212
Chandler 195
Jacksonville 159
Ho Chi Minh City 101
Seoul 97
Beijing 76
Dallas 76
Hanoi 71
Bremen 70
Princeton 69
Roxbury 69
Hefei 63
Dong Ket 60
New York 57
Los Angeles 54
Council Bluffs 52
Medford 46
São Paulo 41
Ann Arbor 38
Aversa 38
The Dalles 37
Caserta 34
Naples 32
Munich 30
Bengaluru 28
Orem 27
Memphis 25
Napoli 24
Wilmington 24
Cambridge 23
San Francisco 23
Atlanta 19
Chicago 19
Da Nang 19
Woodbridge 18
Des Moines 17
Rio de Janeiro 16
Toronto 16
Montreal 14
Nuremberg 14
Denver 13
Milan 13
Brooklyn 12
London 12
Nanjing 12
Salerno 12
Brno 11
Brussels 11
Falkenstein 11
Hanover 11
Helsinki 11
Phoenix 11
Rome 11
Chennai 10
Mexico City 10
Phủ Lý 10
Mountain View 9
Amsterdam 8
Biên Hòa 8
Haiphong 8
Hải Dương 8
Jinan 8
Johannesburg 8
Tashkent 8
Brasília 7
Changsha 7
Columbus 7
Curitiba 7
Guangzhou 7
Jakarta 7
Norwalk 7
Turku 7
Warsaw 7
Boardman 6
Düsseldorf 6
Frankfurt am Main 6
Kunming 6
Manchester 6
Newark 6
Piracicaba 6
Redwood City 6
Auburn Hills 5
Baghdad 5
Belo Horizonte 5
Boston 5
Buffalo 5
City of London 5
Dearborn 5
Guayaquil 5
Houston 5
Istanbul 5
New Delhi 5
Quito 5
Tirana 5
Totale 5.917
Salva come PNG Salva come JPEG
Nome #
Hyponatremia following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review 416
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 197
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 188
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 183
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 182
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 181
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 181
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 176
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 169
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 169
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 159
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 158
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 158
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 157
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 154
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 149
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 148
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 147
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 146
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression 146
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 145
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 144
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 141
Current pharmacological treatments for COVID-19: What's next? 140
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 136
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 136
Disclosing negative trial results – procedure 136
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 134
Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study 129
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 129
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 128
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 126
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 126
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 125
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 122
Disclosure of negative trial results. A call for action 122
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 119
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 119
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 118
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 117
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 116
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 116
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system 115
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 115
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 115
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System 114
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 114
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 113
Influenza vaccine hesitancy in patients with multiple sclerosis: A monocentric observational study 113
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report 112
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies 111
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 110
Therapeutic strategies to fight COVID-19: Which is the status artis? 110
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 109
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 108
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 108
Renin-angiotensin system and coronavirus disease 2019: A narrative review 108
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 107
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 107
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 106
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 106
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 104
Two Unexpected Cases of Rosacea during Fingolimod Therapy 104
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 104
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 104
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 102
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 101
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 100
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 99
The European clinical trials regulation (No 536/2014): changes and challenges 98
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 98
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 98
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 97
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 95
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 94
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 93
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data 91
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 90
Italian immunization goals: A political or scientific heated debate? 88
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study 88
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust 87
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 87
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? 87
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 86
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 84
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression 81
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 80
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy 79
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 78
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 77
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 76
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study 40
null 18
Facts and figures of the compassionate use of onco-hematological drugs from 2016 to 2021: Results from the multicentric observational study Compass-O 13
Hepatobiliary disorders and Direct-Acting Antiviral (DAA) therapies: real-world evidence and insights from the EudraVigilance database 10
Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database 7
Totale 11.327
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022398 0 7 11 5 126 13 19 14 21 18 23 141
2022/2023981 134 36 18 60 107 59 6 47 467 4 25 18
2023/2024407 24 3 15 13 135 13 7 72 12 3 34 76
2024/20251.413 6 21 20 32 204 178 238 116 223 127 131 117
2025/20266.640 285 305 315 358 562 3.524 254 372 239 236 121 69
2026/2027533 404 129 0 0 0 0 0 0 0 0 0 0
Totale 11.327